To include your compound in the COVID-19 Resource Center, submit it here.

PhRMA, BIO: disclosing drug prices in ads not beneficial to patients

PhRMA and BIO said the passage of a Senate amendment that would require biopharma companies to disclose drug list

Read the full 198 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE